SCHEMBL23975555

SCHEMBL23975555

O=C(O)C1CC2CC(C1)CC1CC1C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.44
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 2/20 0.36
GABRR1 P24046 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
ALOX15 P16050 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
TSHR P16473 2/20 0.33
APLNR P35414 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466954 0.89 CYP2C19 (0.43) HSD11B1HSD17B10L3MBTL1CYP2C19GABRR1
SCHEMBL3281806 0.83
SCHEMBL1423806 0.83
SCHEMBL1154498 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL962778 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL15847455 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL15847457 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL1154497 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL15847453 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19
SCHEMBL15858213 0.79 CYP2C19 (0.36) HSD11B1HSD17B10L3MBTL1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11822241-B2 Salt, acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 US disclosed
US-20210341836-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210341836-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN H1-10, H1-0, CHRM1 HSD11B1 578/4885HSD17B10 455/4885L3MBTL1 1002/4885
US-11822241-B2 Salt, acid generator, resist composition and method for producing resist pattern H1-10, H1-0, CHRM1 HSD11B1 578/4885HSD17B10 455/4885L3MBTL1 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.